scholarly journals DNA methylation consistency implicates the primary tumor cell origin of recurrent hepatocellular carcinoma

Epigenomics ◽  
2015 ◽  
Vol 7 (4) ◽  
pp. 581-592 ◽  
Author(s):  
Xiaolei Zhang ◽  
Shuang Liu ◽  
Congle Shen ◽  
Yali Wu ◽  
Ling Zhang ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Dna Methylation ◽  
Tumor Cell ◽  
Primary Tumor ◽  
Recurrent Hepatocellular Carcinoma ◽  
Primary Tumor Cell

scholarly journals Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression

2021 ◽  
Author(s):  
Jan-Paul Gundlach ◽  
Charlotte Hauser ◽  
Franka Maria Schlegel ◽  
Anna Willms ◽  
Christine Halske ◽  
...  
Keyword(s):  
Lymph Node ◽  
Tumor Cell ◽  
Pancreatic Ductal Adenocarcinoma ◽  
Primary Tumor ◽  
Tumor Tissue ◽  
Cultured Cells ◽  
Ductal Adenocarcinoma ◽  
Nuclear Staining ◽  
Cell Nuclei ◽  
Primary Tumor Cell

Abstract Purpose HMGA2 has frequently been found in benign as well as malignant tumors and a significant association between HMGA2 overexpression and poor survival in different malignancies was described. In pancreatic ductal adenocarcinoma (PDAC), nuclear HMGA2 expression is associated with tumor dedifferentiation and presence of lymph node metastasis. Nevertheless, the impact of HMGA2 occurrence in other cell compartments is unknown. Methods Intracellular distribution of HMGA2 was analyzed in PDAC (n = 106) and peritumoral, non-malignant ducts (n = 28) by immunohistochemistry. Findings were correlated with clinico-pathological data. Additionally, intracellular HMGA2 presence was studied by Western blotting of cytoplasmic and nuclear fractions of cultured cells. Results HMGA2 was found in the cytoplasm and in the nucleus of cultured cells. In human tumor tissue, HMGA2 was also frequently found in the cytoplasm and the nucleus of tumor cells, however, nuclear staining was generally stronger. Direct comparison from tumor tissue with corresponding non-neoplastic peritumoral tissue revealed significantly stronger expression in tumors (p = 0.003). Of note, the nuclear staining was significantly stronger in lymph node metastatic cell nuclei compared to primary tumor cell nuclei (p = 0.049). Interestingly, cytoplasmic staining positively correlated with lymph vessel (p = 0.004) and venous invasion (p = 0.046). Conclusion HMGA2 is a prognostic marker in PDAC. Firstly, we found a positive correlation for cytoplasmic HMGA2 expression with lympho-vascular invasion and, secondly, we found a significantly stronger nuclear expression of HMGA2 in cancer-positive lymph node nuclei compared to primary tumor cell nuclei. So far, the role of cytoplasmic HMGA2 is nearly unknown, however, our data lend support to the hypothesis that cytoplasmic HMGA2 expression is involved in nodal spread.

Sign in / Sign up

Export Citation Format

Share Document